Literature DB >> 29902388

Phthisis Bulbi-a Clinicopathological Perspective.

Koushik Tripathy1, Rohan Chawla1, Shreyas Temkar1, Pradeep Sagar1, Seema Kashyap2, Neelam Pushker1, Yog Raj Sharma1.   

Abstract

Phthisis bulbi denotes end-stage eye disease characterized by shrinkage and disorganization of the eye with the resultant functional loss. The major factors associated with the pathogenesis of phthisis are hypotony, deranged blood-ocular barriers, and inflammation. Common causes include trauma, surgery, infection, inflammation, malignancy, retinal detachment, and vascular lesions. A phthisical globe shows a small squared off shape, opaque and thickened cornea, thickened sclera, neovascularization of iris, cataract, cyclitic membrane, ciliochoroidal detachment, and retinal detachment. Microscopic features include internal disorganization, inflammatory reaction, a reactive proliferation of various cells, calcification, and ossification. Early treatment of the causative etiology is the best strategy available to avoid an eye from going into phthisis. A phthisical eye has no visual potential and cosmetic rehabilitation or symptomatic relief of pain remains the mainstay in the management. The authors present a comprehensive review of the etiopathogenesis, pathology, clinical features, and management of the end-stage ocular disease.

Entities:  

Keywords:  Atrophic bulbi; end-stage eye; hypotony; phthisical eye; terminal eye disease

Mesh:

Year:  2018        PMID: 29902388     DOI: 10.1080/08820538.2018.1477966

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  9 in total

1.  Phthisis Bulbi in a Retinitis Pigmentosa Patient after Argus II Implantation.

Authors:  Logan Vander Woude; Ramak Roohipour; Gibran Syed Khurshid
Journal:  Case Rep Ophthalmol Med       Date:  2020-08-17

2.  The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey.

Authors:  Enver Mirza; Gunsu Deniz Mirza; Refik Oltulu; Mehmet Okka; Ahmet Ozkagnici
Journal:  Eurasian J Med       Date:  2019-10

Review 3.  Bicarbonate, carbon dioxide and pH sensing via mammalian bicarbonate-regulated soluble adenylyl cyclase.

Authors:  Tom Rossetti; Stephanie Jackvony; Jochen Buck; Lonny R Levin
Journal:  Interface Focus       Date:  2021-02-12       Impact factor: 3.906

4.  Iris melanoma associated with unilateral phthisis bulbi in a 13-year-old domestic shorthair female cat.

Authors:  Barbara Lamagna; Valeria Uccello; Francesco Prisco; Valeria Russo; Francesco Lamagna; Luigi Navas; Giuseppina Mennonna; Carla Murino; Leonardo Meomartino
Journal:  Vet Q       Date:  2019-12       Impact factor: 3.320

5.  Transgenic Mice Overexpressing PG1 Display Corneal Opacity and Severe Inflammation in the Eye.

Authors:  Min-Kyeung Choi; Minh Thong Le; Hye-Sun Cho; Juyoung Lee; Hyoim Jeon; Se-Yeoun Cha; Manheum Na; Taehoon Chun; Jin-Hoi Kim; Hyuk Song; Chankyu Park
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

6.  Penetrating keratoplasty using collagen crosslinked donor tissue: A case report.

Authors:  Sila Bal; Joseph B Ciolino
Journal:  Am J Ophthalmol Case Rep       Date:  2021-02-24

7.  Distribution of phthisis bulbi and status of fellow eyes at a tertiary eye-care centre in Nigeria: a ten-year review.

Authors:  Bolajoko A Adewara; Sarat A Badmus; Olukemi T Olugbade; Edak Ezeanosike; Bernice O Adegbehingbe
Journal:  Afr Health Sci       Date:  2021-03       Impact factor: 0.927

8.  Two 11-Years Periods Statistics and Trends of Enucleation and Evisceration.

Authors:  Alena Furdova; Kristina Horkovicova; Robert Furda; Miron Sramka; Jan Rybar; Pavol Kusenda; Zuzana Pridavkova
Journal:  J Craniofac Surg       Date:  2021 Nov-Dec 01       Impact factor: 1.172

9.  A case of retinoblastoma resulting in phthisis bulbi after proton beam radiation therapy.

Authors:  Norihiko Nakagawa; Takeshi Morimoto; Takako Miyamura; Shigenobu Suzuki; Hiroshi Shimojo; Kohji Nishida
Journal:  Am J Ophthalmol Case Rep       Date:  2022-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.